Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
Summary
Jubilant Life Sciences Limited (Jubilant), formerly Jubilant Organosys Limited, is a pharmaceutical and life sciences company. It carries out the research and development of advanced and innovative technologies in the fields of drug discovery and development services to suit the requirements of the healthcare markets across the world. The company specializes in providing generic and new drugs, besides industrial and performance products. The company has state-of-the-art manufacturing facilities in eight centers, namely, Gajraula (UP), Nanjangud (Karnataka), Roorkee (Uttarakhand), Nira (Maharashtra), Udaipur (Rajasthan), Samlaya (Gujarat), Salisbury, Maryland (US) and Spokane, Washington (US). Geographically, the company operates in India, Belgium, Canada, China, Greenland, and the US. Jubilant is headquartered in Noida, India.
The key business strategies of the company include providing high quality life science products and services across the value chain and serving its customers globally with its presence in North America, India, Europe and China. It also aims to maintain its existing partnerships and enter into new collaborative agreements to augment its services. This aim is evident in its recent partnership and drug discovery collaboration with Mnemosyne Pharmaceutical Inc. for identifying preclinical candidates in the area of neuropsychiatric diseases; a discovery partnership with Norgine for developing multiple targets for treating gastrointestinal diseases; and a multimillion dollar contract with a US pharmaceutical company for manufacturing an OTC women’s health and personal care product. It also entered into a strategic partnership with a Sweden-based company, SEKAB BioFuels & Chemicals AB, for marketing its two major life science chemical products, namely, Bio-Ethyl Acetate and Acetic Anhydride, in the European markets; and a drug discovery alliance with Janssen Pharmaceutica N.V. for delivering preclinical candidates to Janssen.
Jubilant Life Sciences Limited Key Recent Developments
Feb 22, 2012: Jubilant HollisterStier Announces $90m Contract For Manufacture Of Sterile Parenteral Products
Feb 09, 2012: Jubilant And Endo Pharmaceuticals Announce Successful Delivery Of Early Milestones In Collaborative Discovery Program
Feb 06, 2012: Jubilant Life Sciences Reports Net Sales Of INR10.9 Billion In Q3 Fiscal 2012
Nov 01, 2011: Jubilant Life Sciences Reports Net Sales Of INR10.5 Billion In Q2 Fiscal 2012
Oct 11, 2011: Jubilant Starts Commercial Production Of Niacinamide And 3 Cyanopyridne From New 10,000 TPA Facility
This comprehensive SWOT profile of Jubilant Life Sciences Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
Summary
Jubilant Life Sciences Limited (Jubilant), formerly Jubilant Organosys Limited, is a pharmaceutical and life sciences company. It carries out the research and development of advanced and innovative technologies in the fields of drug discovery and development services to suit the requirements of the healthcare markets across the world. The company specializes in providing generic and new drugs, besides industrial and performance products. The company has state-of-the-art manufacturing facilities in eight centers, namely, Gajraula (UP), Nanjangud (Karnataka), Roorkee (Uttarakhand), Nira (Maharashtra), Udaipur (Rajasthan), Samlaya (Gujarat), Salisbury, Maryland (US) and Spokane, Washington (US). Geographically, the company operates in India, Belgium, Canada, China, Greenland, and the US. Jubilant is headquartered in Noida, India.
The key business strategies of the company include providing high quality life science products and services across the value chain and serving its customers globally with its presence in North America, India, Europe and China. It also aims to maintain its existing partnerships and enter into new collaborative agreements to augment its services. This aim is evident in its recent partnership and drug discovery collaboration with Mnemosyne Pharmaceutical Inc. for identifying preclinical candidates in the area of neuropsychiatric diseases; a discovery partnership with Norgine for developing multiple targets for treating gastrointestinal diseases; and a multimillion dollar contract with a US pharmaceutical company for manufacturing an OTC women’s health and personal care product. It also entered into a strategic partnership with a Sweden-based company, SEKAB BioFuels & Chemicals AB, for marketing its two major life science chemical products, namely, Bio-Ethyl Acetate and Acetic Anhydride, in the European markets; and a drug discovery alliance with Janssen Pharmaceutica N.V. for delivering preclinical candidates to Janssen.
Jubilant Life Sciences Limited Key Recent Developments
Feb 22, 2012: Jubilant HollisterStier Announces $90m Contract For Manufacture Of Sterile Parenteral Products
Feb 09, 2012: Jubilant And Endo Pharmaceuticals Announce Successful Delivery Of Early Milestones In Collaborative Discovery Program
Feb 06, 2012: Jubilant Life Sciences Reports Net Sales Of INR10.9 Billion In Q3 Fiscal 2012
Nov 01, 2011: Jubilant Life Sciences Reports Net Sales Of INR10.5 Billion In Q2 Fiscal 2012
Oct 11, 2011: Jubilant Starts Commercial Production Of Niacinamide And 3 Cyanopyridne From New 10,000 TPA Facility
This comprehensive SWOT profile of Jubilant Life Sciences Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Contents
SECTION 1 - ABOUT THE COMPANYJubilant Life Sciences Limited - Key Facts
Jubilant Life Sciences Limited - Key Employees
Jubilant Life Sciences Limited - Key Employee Biographies
Jubilant Life Sciences Limited - Major Products and Services
Jubilant Life Sciences Limited - History
Jubilant Life Sciences Limited - Company Statement
Jubilant Life Sciences Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Jubilant Life Sciences Limited - Key Manufacturing Facilities
SECTION 2 – COMPANY ANALYSIS
Jubilant Life Sciences Limited - Business Description
Jubilant Life Sciences Limited - Corporate Strategy
Jubilant Life Sciences Limited - SWOT Analysis
SWOT Analysis - Overview
Jubilant Life Sciences Limited - Strengths
Strength - Extensive Range of Solutions
Strength - Operational Base
Strength - Industry Leading Position
Jubilant Life Sciences Limited - Weaknesses
Weakness - Substantial Debt Burden
Weakness - Weak Profitability Indicators
Jubilant Life Sciences Limited - Opportunities
Opportunity - Growth Prospects: Pharmaceutical Outsourcing
Opportunity - Growth Prospects: Indian Pharmaceutical Market
Opportunity - New Business Contracts and Collaborations
Jubilant Life Sciences Limited - Threats
Threat - Industry Consolidation
Threat - Government Regulations
Threat - Competitive Landscape
Threat - Global Economic Scenario
Jubilant Life Sciences Limited - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Jubilant Life Sciences Limited, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Jubilant Life Sciences Limited, Recent Developments
Feb 22, 2012: Jubilant HollisterStier Announces $90m Contract For Manufacture Of Sterile Parenteral Products
Feb 09, 2012: Jubilant And Endo Pharmaceuticals Announce Successful Delivery Of Early Milestones In Collaborative Discovery Program
Feb 06, 2012: Jubilant Life Sciences Reports Net Sales Of INR10.9 Billion In Q3 Fiscal 2012
Nov 01, 2011: Jubilant Life Sciences Reports Net Sales Of INR10.5 Billion In Q2 Fiscal 2012
Oct 11, 2011: Jubilant Starts Commercial Production Of Niacinamide And 3 Cyanopyridne From New 10,000 TPA Facility
Sep 14, 2011: Jubilant Life Sciences Signs Multi Million Dollar Contract To Manufacture OTC Women Health Product
Aug 09, 2011: Jubilant Reports Net Sales Of INR9.44 Billion In Q1 Fiscal 2012
Aug 09, 2011: Jubilant Reports Net Sales Of INR9.44 Billion In Q1 Fiscal 2012
May 10, 2011: Jubilant Life Sciences Reports Net Sales Of INR8.9 Billion In Q4 Fiscal 2011
Feb 14, 2011: Jubilant Life Sciences Reports Net Sales Of INR8.7 Billion In Q3 Fiscal 2011
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Jubilant Life Sciences Limited, Key Facts
Jubilant Life Sciences Limited, Key Employees
Jubilant Life Sciences Limited, Key Employee Biographies
Jubilant Life Sciences Limited, Major Products and Services
Jubilant Life Sciences Limited, History
Jubilant Life Sciences Limited, Other Locations
Jubilant Life Sciences Limited, Subsidiaries
Jubilant Life Sciences Limited, Key Manufacturing Facilities
Jubilant Life Sciences Limited, Key Competitors
Jubilant Life Sciences Limited, Ratios based on current share price
Jubilant Life Sciences Limited, Annual Ratios
Jubilant Life Sciences Limited, Interim Ratios
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Jubilant Life Sciences Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Jubilant Life Sciences Limited, Performance Chart (2007 - 2011)
Jubilant Life Sciences Limited, Ratio Charts
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012 Skip to top